The use of leukodepleted blood components may reduce some adverse effects of transfusion in certain clinical situations. This review outlines the recognised effects of contaminating passenger leucocytes, the value of leukodepleted components in preventing some of these complications, methods of leukodepletion and the current recommendations for use of these components.
TerasakiP.I.Beneficial effect of transfusion on kidney transplantation.Vox Sang1989; 57: 158–160.
2.
TerasakiP.I.The beneficial transfusion effect on kidney graft survival attributed to clonal detection.Transplantation1984; 37: 119–125.
3.
LenhardV., MassenG., SeifertP.Characterization of transfusion-induced suppressor cells in prospective kidney allograft recipients.Transplant Proc1982; 14: 329–332.
4.
SingalD.P., JosephS.Role of blood transfusion the induction of antibodies against recognition sites on T lymphocytes in renal transplant patients.Hum Immunol1982; 4: 93–108.
5.
LagaaijE.L., HennemannP.H., RuigrokM.Effect of one HLA-DR antigen matched and completely HLA-DR-mismatched blood transfusions on the survival of heart and kidney allografts.N Engl J Med1989; 321: 701–705.
6.
TuckerJ., MurphyM.C., GregoryW.M.Apparent removal of graft-vs-leukaemic effect by the use of leucocyte-poor blood components in patients with acute myeloblastic leukaemia.Br J Haematol1989; 73: 572–581.
7.
LopezJ., Fernandez-VillaltaM.J., Gomez-ReinoF.Absence of graft vs leukaemic effect of standard haemotherapy in patients with acute myeloblastic leukaemia.Transfusion1990; 30: 191.
8.
RebullaP., PappaletteraM., BarbuiT.Duration of first remission in leukaemic recipients of leucocyte poor blood components.Br J Haematol1990; 75: 441–442.
9.
PayneR.The association of febrile transfusion reactions with leuko-agglutinins.Vox Sang1957; 2: 233–241.
10.
DecaryF., FernerP., GiavedoniL.An investigation of non haemolytic transfusion reactions.Vox Sang1984; 46: 277–285.
11.
EernisseJ.G., BrandA.Prevention of platelet refractoriness due to HLA antibodies by administration of leukocyte-poor blood components.Exp Haematol1981; 9: 77–83.
12.
HathawayW.E., FulginitiV.A., PierceC.W.Graft-vs-host reaction following a single blood transfusion.JAMA1967; 201: 1015–1020.
13.
ThalerM., ShamissA., OrgadS.The role of blood from HLA-homozygous donors in fatal transfusion-associated graft-vs–host disease after open heart surgery.N Engl J Med1989; 321: 25–28.
14.
PrinceA.M., SzmunessW., MillianS.J.A serologic study of cytomegalovirus infections associated with blood transfusions.N Engl J Med1971; 284: 1125–1131.
15.
PreiksaitisJ.K., BrownL., McKenzieM.The risk of cytomegalovirus infection in seronegative transfusion recipients not receiving exogenous immunosuppression.J Infect Dis1988; 157: 523–529.
16.
OkochiK., SatoH., HinumaJ.A retrospective study on transfusion of adult T cell leukaemia virus by blood transfusion: seroconversion in recipients.Vox Sang1984; 46: 245–253.
17.
TartterP.I.Blood transfusion and post operative infections.Transfusion1989; 29: 456–439.
18.
WaymackJ.P.The effect of blood transfusions on resistance to bacterial infections.Transplant Proc1988; 20: 1105–1107.
19.
BlumbergN., HealJ.M., MurphyP.Association between transfusion of whole blood and recurrence of cancer.Br Med J1986; 293: 530–533.
20.
TartterP.I.Blood transfusion history in colorrectal cancer patients and cancer-free controls.Transfusion1988; 28: 593–596.
21.
BrittinghamT.E., ChapinH.Jr.Febrile transfusion reactions caused by sensitivity to donor leucocytes and platelets.J Am Med Assoc1957; 165: 819–825.
22.
SirchiaG., RebullaP., MascarettiL.The clinical importance of leucocyte depletion in regular erythrocyte transfusions.Vox Sang1986; 51(Suppl 1): 2–8.
23.
SlichterS.J.Transfusion and bone marrow transplantation.Transfus Med Rev1988; 2: 1–17.
24.
HowardJ.E., PerkinsH.A.The natural history of alloimmunization to platelets.Transfusion1978; 78: 496–503.
25.
LeeE.J., SchifferC.A.Serial measurement of lymphocutotoxic antibody and response to non matched platelet transfusions in alloimmunized patients.Blood1987; 70: 1727–1729.
26.
Council of Europe Guidelines for Preparation, Use and Quality Control of (cellular) Blood Components. March, 1989, Strasbourg, France; Council of Europe, 1989.
27.
MurphyM.F., MetcalfeP., ThomasH.Use of leucocyte-poor blood components and HLA-matched platelet donors to prevent HLA alloimmunization.Br J Haematol1986; 62: 529–534.
28.
AndreuG., DewaillyJ., LeberreC.Prevention of HLA alloimmunization with leucocyte-poor packed red cells and platelet concentrates prepared by filtration.Blood1988; 72: 964–969.
29.
International forum.Should all platelet concentrates be leucocyte-poor?Vox Sang1992; 62: 57–64.
30.
SakakibaraT., JujiT.Post transfusion graft-versus-disease after open heart surgery.Lancet1986; ii: 1099.
31.
GilbertA.L., HayesK., HudsonI.L., JamesJ.Prevention of transfusion acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Study Group.Lancet1989; i: 1228–1231.
32.
EiesnfeldL., SilverH., McLaughlinJ.Prevention of transfusion associated cytomegalovirus infection in neonates patients by removal of white cells from blood.Transfusion1992; 32: 205–209.
33.
TartterP.I., DriefussR.M., MalonA.M.Relationship of post operative septic complications and blood transfusion in patients with Crohn's disease.Am J Surg1988; 155: 43–47.
34.
RewalB.D., SchwadranR., BuschM.P., EndowR., VyasG.N.Evaluation of leucocyte removal filters modelled by use of HIV-infected cells and DNA amplification.Blood1990; 76: 2159–2161.
35.
DzikW.H.Leukoreduced blood components: you can filter now or you can filter later.Transfus Sci1992; 13: 207–210.
36.
BrecherM.E., PinedaA.P., TorloniA.S.Prestorage leucocyte depletion: effect on leucocyte and platelet metabolites, erythrocyte lysis, metabolism and in vivo survival.Semin Haematol1991; 28(Suppl): 3–9.
37.
RiednerC., HermM.V., MempelW., WilmannsW.Possibility to improve preservation of whole blood by leukodepletion before storage.Vox Sang1990; 59: 78–82.
38.
DzikW.H., CusackW.F., SherburneB.Prestorage leukodepletion and the platelet storage lesion.Proc of the ISBT/AABB1990, S21.
